UBS Adjusts Price Target on IQVIA to $260 From $300, Maintains Buy Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
197.66 USD | +0.80% | -3.26% | +0.59% |
Jan. 13 | IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions | CI |
Dec. 22 | IQVIA Holdings Inc. acquired Point Of Care Network, LLC. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration